Thrombospondin 1 as a novel biological marker of obesity and metabolic syndrome

Metabolism. 2015 Nov;64(11):1490-9. doi: 10.1016/j.metabol.2015.07.016. Epub 2015 Jul 26.

Abstract

Context: Thrombospondin 1 (THBS1 or TSP-1) is an adipose-derived matricellular protein, which has recently been highlighted as a potential mediator of insulin resistance and adipose inflammation in obesity.

Objective: In this study, we aimed to determine the clinical significance of THBS1 as a novel biological marker of visceral obesity, metabolic syndrome, and diabetes.

Methods: The THBS1 mRNA level was quantified with real-time PCR in human adipose tissues obtained from 16 non-obese subjects. The relationships between serum THBS1 level and obesity/diabetes traits as well as the diagnostic components of metabolic syndrome were assessed in 164 normal-weight or overweight/obese subjects (78 males and 86 females; mean age, 50.4; mean BMI, 29.8) with analysis of covariance (ANCOVA) and regression analyses.

Results: THBS1 was predominantly expressed in visceral adipose tissues relative to subcutaneous adipose tissues (P<0.001). The visceral THBS1 expression was positively associated with the body mass index (BMI; γs=0.54, P=0.033). ANCOVA demonstrated that the THBS1 level is associated with abdominal obesity (P<0.001), hyperglycemia (P=0.02), and hypertension (P=0.04). Multivariable regression analysis suggested an association between serum THBS1 and fasting plasma glucose levels. The associations between serum THBS1 levels and obesity/diabetes traits were found preferentially in women (BMI, γs=0.30, P=0.05; FPG, γs=0.26, P=0.016). Subanalyses demonstrated that the association with obesity traits was predominantly found in premenopausal women (BMI, γs=0.41, P=0.007), whereas the association with diabetes traits was predominant in postmenopausal women (HbA1c, γs=0.38, P=0.01). During medical weight reduction treatment, the change in the serum THBS1 level was associated with the change in BMI and HbA1c in pre- and postmenopausal women, respectively.

Conclusions: Serum THBS1 is a useful biological marker of obesity and metabolic syndrome in Japanese subjects, particularly in women. THBS1 may act as a critical circulating factor that couples obesity with metabolic syndrome and diabetes in humans.

Keywords: Biological marker; Diabetes; Metabolic syndrome; Obesity; Thrombospondin 1.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Biomarkers / blood
  • Biomarkers / metabolism*
  • Female
  • Humans
  • Intra-Abdominal Fat / metabolism
  • Male
  • Metabolic Syndrome / diagnosis*
  • Metabolic Syndrome / metabolism
  • Middle Aged
  • Obesity / diagnosis*
  • Obesity / metabolism
  • Obesity / therapy
  • Postmenopause
  • Premenopause
  • RNA, Messenger / metabolism
  • Thrombospondin 1 / blood
  • Thrombospondin 1 / genetics
  • Thrombospondin 1 / metabolism*
  • Weight Loss

Substances

  • Biomarkers
  • RNA, Messenger
  • Thrombospondin 1

Associated data

  • JPRN/UMIN000016823